Advertisement

Index by author

April 01, 1989; Volume 35,Issue 4

A

  1. Abe, A

    1. Expression of a human P-450IIC gene in yeast cells using galactose-inducible expression system.
      T Yasumori, N Murayama, Y Yamazoe, A Abe, Y Nogi, T Fukasawa and R Kato
      Molecular Pharmacology April 1989, 35 (4) 443-449;

  2. Alho, H

    1. In primary cultures of cerebellar granule cells the activation of N-methyl-D-aspartate-sensitive glutamate receptors induces c-fos mRNA expression.
      A M Szekely, M L Barbaccia, H Alho and E Costa
      Molecular Pharmacology April 1989, 35 (4) 401-408;

B

  1. Barbaccia, M L

    1. In primary cultures of cerebellar granule cells the activation of N-methyl-D-aspartate-sensitive glutamate receptors induces c-fos mRNA expression.
      A M Szekely, M L Barbaccia, H Alho and E Costa
      Molecular Pharmacology April 1989, 35 (4) 401-408;

  2. Barrett, R W

    1. Type-A cholecystokinin receptors in CHP212 neuroblastoma cells: evidence for association with G protein and activation of phosphoinositide hydrolysis.
      R W Barrett, M E Steffey and C A Wolfram
      Molecular Pharmacology April 1989, 35 (4) 394-400;

  3. Beck, S G

    1. Pertussis toxin-sensitive guanine nucleotide-binding protein(S) couple adenosine A1 and 5-hydroxytryptamine1A receptors to the same effector systems in rat hippocampus: biochemical and electrophysiological studies.
      J M Zgombick, S G Beck, C D Mahle, B Craddock-Royal and S Maayani
      Molecular Pharmacology April 1989, 35 (4) 484-494;

  4. Beckmann, R P

    1. Use of an inducible hybrid viral gene as a model for evaluating drug effects on gene expression.
      R P Beckmann and T A Beerman
      Molecular Pharmacology April 1989, 35 (4) 433-442;

  5. Beerman, T A

    1. Use of an inducible hybrid viral gene as a model for evaluating drug effects on gene expression.
      R P Beckmann and T A Beerman
      Molecular Pharmacology April 1989, 35 (4) 433-442;

  6. Belinsky, S A

    1. Interactions between glycolysis and mixed function oxidation: studies with 7-ethoxycoumarin in perfused livers from beta-naphthoflavone-treated rats.
      S A Belinsky, F C Kauffman and R G Thurman
      Molecular Pharmacology April 1989, 35 (4) 512-518;

  7. Berger, S H

    1. Modulation of 5-fluoro-2'-deoxyuridine response by folinic acid in human colonic tumor cell lines: the role of thymidylate synthase.
      S T Davis and S H Berger
      Molecular Pharmacology April 1989, 35 (4) 422-427;

  8. Berrie, C P

    1. Phosphatidylinositol 4,5-bisphosphate hydrolysis in turkey erythrocytes is regulated by P2y purinoceptors.
      C P Berrie, P T Hawkins, L R Stephens, T K Harden and C P Downes
      Molecular Pharmacology April 1989, 35 (4) 526-532;

  9. Birdsall, N J

    1. The existence of stable enantiomers of telenzepine and their stereoselective interaction with muscarinic receptor subtypes.
      P Eveleigh, E C Hulme, C Schudt and N J Birdsall
      Molecular Pharmacology April 1989, 35 (4) 477-483;

  10. Bonner, T I

    1. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
      N J Buckley, T I Bonner, C M Buckley and M R Brann
      Molecular Pharmacology April 1989, 35 (4) 469-476;

  11. Brann, M R

    1. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
      N J Buckley, T I Bonner, C M Buckley and M R Brann
      Molecular Pharmacology April 1989, 35 (4) 469-476;

  12. Buckley, C M

    1. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
      N J Buckley, T I Bonner, C M Buckley and M R Brann
      Molecular Pharmacology April 1989, 35 (4) 469-476;

  13. Buckley, N J

    1. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
      N J Buckley, T I Bonner, C M Buckley and M R Brann
      Molecular Pharmacology April 1989, 35 (4) 469-476;

  14. Busche, R

    1. Preparation and utility of a radioiodinated analogue of daunomycin in the study of multidrug resistance.
      R Busche, B Tümmler, J R Riordan and D F Cano-Gauci
      Molecular Pharmacology April 1989, 35 (4) 414-421;

C

  1. Cano-Gauci, D F

    1. Preparation and utility of a radioiodinated analogue of daunomycin in the study of multidrug resistance.
      R Busche, B Tümmler, J R Riordan and D F Cano-Gauci
      Molecular Pharmacology April 1989, 35 (4) 414-421;

  2. Ciriolo, M R

    1. Transfer RNA is cleaved by activated bleomycin.
      R S Magliozzo, J Peisach and M R Ciriolo
      Molecular Pharmacology April 1989, 35 (4) 428-432;

  3. Costa, E

    1. In primary cultures of cerebellar granule cells the activation of N-methyl-D-aspartate-sensitive glutamate receptors induces c-fos mRNA expression.
      A M Szekely, M L Barbaccia, H Alho and E Costa
      Molecular Pharmacology April 1989, 35 (4) 401-408;

  4. Craddock-Royal, B

    1. Pertussis toxin-sensitive guanine nucleotide-binding protein(S) couple adenosine A1 and 5-hydroxytryptamine1A receptors to the same effector systems in rat hippocampus: biochemical and electrophysiological studies.
      J M Zgombick, S G Beck, C D Mahle, B Craddock-Royal and S Maayani
      Molecular Pharmacology April 1989, 35 (4) 484-494;

D

  1. Davis, S T

    1. Modulation of 5-fluoro-2'-deoxyuridine response by folinic acid in human colonic tumor cell lines: the role of thymidylate synthase.
      S T Davis and S H Berger
      Molecular Pharmacology April 1989, 35 (4) 422-427;

  2. Dhar, A

    1. Desensitization of platelet-activating factor-stimulated protein phosphorylation in platelets.
      S D Shukla, W J Morrison and A Dhar
      Molecular Pharmacology April 1989, 35 (4) 409-413;

  3. Downes, C P

    1. Phosphatidylinositol 4,5-bisphosphate hydrolysis in turkey erythrocytes is regulated by P2y purinoceptors.
      C P Berrie, P T Hawkins, L R Stephens, T K Harden and C P Downes
      Molecular Pharmacology April 1989, 35 (4) 526-532;

E

  1. Eveleigh, P

    1. The existence of stable enantiomers of telenzepine and their stereoselective interaction with muscarinic receptor subtypes.
      P Eveleigh, E C Hulme, C Schudt and N J Birdsall
      Molecular Pharmacology April 1989, 35 (4) 477-483;

F

  1. Fukasawa, T

    1. Expression of a human P-450IIC gene in yeast cells using galactose-inducible expression system.
      T Yasumori, N Murayama, Y Yamazoe, A Abe, Y Nogi, T Fukasawa and R Kato
      Molecular Pharmacology April 1989, 35 (4) 443-449;

H

  1. Harden, T K

    1. Phosphatidylinositol 4,5-bisphosphate hydrolysis in turkey erythrocytes is regulated by P2y purinoceptors.
      C P Berrie, P T Hawkins, L R Stephens, T K Harden and C P Downes
      Molecular Pharmacology April 1989, 35 (4) 526-532;

  2. Hawkins, P T

    1. Phosphatidylinositol 4,5-bisphosphate hydrolysis in turkey erythrocytes is regulated by P2y purinoceptors.
      C P Berrie, P T Hawkins, L R Stephens, T K Harden and C P Downes
      Molecular Pharmacology April 1989, 35 (4) 526-532;

  3. Hinkle, P M

    1. Solubilization and characterization of pituitary thyrotropin-releasing hormone receptors.
      W J Phillips and P M Hinkle
      Molecular Pharmacology April 1989, 35 (4) 533-540;

  4. Hulme, E C

    1. The existence of stable enantiomers of telenzepine and their stereoselective interaction with muscarinic receptor subtypes.
      P Eveleigh, E C Hulme, C Schudt and N J Birdsall
      Molecular Pharmacology April 1989, 35 (4) 477-483;

J

  1. Javitt, D C

    1. Biexponential kinetics of [3H]MK-801 binding: evidence for access to closed and open N-methyl-D-aspartate receptor channels.
      D C Javitt and S R Zukin
      Molecular Pharmacology April 1989, 35 (4) 387-393;

K

  1. Kato, R

    1. Expression of a human P-450IIC gene in yeast cells using galactose-inducible expression system.
      T Yasumori, N Murayama, Y Yamazoe, A Abe, Y Nogi, T Fukasawa and R Kato
      Molecular Pharmacology April 1989, 35 (4) 443-449;

  2. Kauffman, F C

    1. Interactions between glycolysis and mixed function oxidation: studies with 7-ethoxycoumarin in perfused livers from beta-naphthoflavone-treated rats.
      S A Belinsky, F C Kauffman and R G Thurman
      Molecular Pharmacology April 1989, 35 (4) 512-518;

  3. Kriwacki, R W

    1. The conformational analysis of delta 9- and delta 9,11-tetrahydrocannabinols in solution using high resolution nuclear magnetic resonance spectroscopy.
      R W Kriwacki and A Makriyannis
      Molecular Pharmacology April 1989, 35 (4) 495-503;

  4. Kubow, S

    1. In vitro bioactivation of phenytoin to a reactive free radical intermediate by prostaglandin synthetase, horseradish peroxidase, and thyroid peroxidase.
      S Kubow and P G Wells
      Molecular Pharmacology April 1989, 35 (4) 504-511;

L

  1. Leblanc, G A

    1. Hypophysectomy differentially alters P-450 protein levels and enzyme activities in rat liver: pituitary control of hepatic NADPH cytochrome P-450 reductase.
      D J Waxman, J J Morrissey and G A Leblanc
      Molecular Pharmacology April 1989, 35 (4) 519-525;

  2. Leid, M

    1. Agonist radioligand interactions with the solubilized porcine atrial A1 adenosine receptor.
      M Leid, M I Schimerlik and T F Murray
      Molecular Pharmacology April 1989, 35 (4) 450-457;

M

  1. Maayani, S

    1. Pertussis toxin-sensitive guanine nucleotide-binding protein(S) couple adenosine A1 and 5-hydroxytryptamine1A receptors to the same effector systems in rat hippocampus: biochemical and electrophysiological studies.
      J M Zgombick, S G Beck, C D Mahle, B Craddock-Royal and S Maayani
      Molecular Pharmacology April 1989, 35 (4) 484-494;

  2. Magliozzo, R S

    1. Transfer RNA is cleaved by activated bleomycin.
      R S Magliozzo, J Peisach and M R Ciriolo
      Molecular Pharmacology April 1989, 35 (4) 428-432;

  3. Mahle, C D

    1. Pertussis toxin-sensitive guanine nucleotide-binding protein(S) couple adenosine A1 and 5-hydroxytryptamine1A receptors to the same effector systems in rat hippocampus: biochemical and electrophysiological studies.
      J M Zgombick, S G Beck, C D Mahle, B Craddock-Royal and S Maayani
      Molecular Pharmacology April 1989, 35 (4) 484-494;

  4. Makriyannis, A

    1. The conformational analysis of delta 9- and delta 9,11-tetrahydrocannabinols in solution using high resolution nuclear magnetic resonance spectroscopy.
      R W Kriwacki and A Makriyannis
      Molecular Pharmacology April 1989, 35 (4) 495-503;

  5. Morrison, W J

    1. Desensitization of platelet-activating factor-stimulated protein phosphorylation in platelets.
      S D Shukla, W J Morrison and A Dhar
      Molecular Pharmacology April 1989, 35 (4) 409-413;

  6. Morrissey, J J

    1. Hypophysectomy differentially alters P-450 protein levels and enzyme activities in rat liver: pituitary control of hepatic NADPH cytochrome P-450 reductase.
      D J Waxman, J J Morrissey and G A Leblanc
      Molecular Pharmacology April 1989, 35 (4) 519-525;

  7. Murayama, N

    1. Expression of a human P-450IIC gene in yeast cells using galactose-inducible expression system.
      T Yasumori, N Murayama, Y Yamazoe, A Abe, Y Nogi, T Fukasawa and R Kato
      Molecular Pharmacology April 1989, 35 (4) 443-449;

  8. Murray, T F

    1. Agonist radioligand interactions with the solubilized porcine atrial A1 adenosine receptor.
      M Leid, M I Schimerlik and T F Murray
      Molecular Pharmacology April 1989, 35 (4) 450-457;

N

  1. Nogi, Y

    1. Expression of a human P-450IIC gene in yeast cells using galactose-inducible expression system.
      T Yasumori, N Murayama, Y Yamazoe, A Abe, Y Nogi, T Fukasawa and R Kato
      Molecular Pharmacology April 1989, 35 (4) 443-449;

P

  1. Peisach, J

    1. Transfer RNA is cleaved by activated bleomycin.
      R S Magliozzo, J Peisach and M R Ciriolo
      Molecular Pharmacology April 1989, 35 (4) 428-432;

  2. Phillips, W J

    1. Solubilization and characterization of pituitary thyrotropin-releasing hormone receptors.
      W J Phillips and P M Hinkle
      Molecular Pharmacology April 1989, 35 (4) 533-540;

R

  1. Riordan, J R

    1. Preparation and utility of a radioiodinated analogue of daunomycin in the study of multidrug resistance.
      R Busche, B Tümmler, J R Riordan and D F Cano-Gauci
      Molecular Pharmacology April 1989, 35 (4) 414-421;

  2. Rogawski, M A

    1. Aminopyridines enhance opening of calcium-activated potassium channels in GH3 anterior pituitary cells.
      M A Rogawski
      Molecular Pharmacology April 1989, 35 (4) 458-468;

  3. Rutledge, A

    1. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
      X Y Wei, A Rutledge and D J Triggle
      Molecular Pharmacology April 1989, 35 (4) 541-552;

S

  1. Schimerlik, M I

    1. Agonist radioligand interactions with the solubilized porcine atrial A1 adenosine receptor.
      M Leid, M I Schimerlik and T F Murray
      Molecular Pharmacology April 1989, 35 (4) 450-457;

  2. Schudt, C

    1. The existence of stable enantiomers of telenzepine and their stereoselective interaction with muscarinic receptor subtypes.
      P Eveleigh, E C Hulme, C Schudt and N J Birdsall
      Molecular Pharmacology April 1989, 35 (4) 477-483;

  3. Shukla, S D

    1. Desensitization of platelet-activating factor-stimulated protein phosphorylation in platelets.
      S D Shukla, W J Morrison and A Dhar
      Molecular Pharmacology April 1989, 35 (4) 409-413;

  4. Steffey, M E

    1. Type-A cholecystokinin receptors in CHP212 neuroblastoma cells: evidence for association with G protein and activation of phosphoinositide hydrolysis.
      R W Barrett, M E Steffey and C A Wolfram
      Molecular Pharmacology April 1989, 35 (4) 394-400;

  5. Stephens, L R

    1. Phosphatidylinositol 4,5-bisphosphate hydrolysis in turkey erythrocytes is regulated by P2y purinoceptors.
      C P Berrie, P T Hawkins, L R Stephens, T K Harden and C P Downes
      Molecular Pharmacology April 1989, 35 (4) 526-532;

  6. Szekely, A M

    1. In primary cultures of cerebellar granule cells the activation of N-methyl-D-aspartate-sensitive glutamate receptors induces c-fos mRNA expression.
      A M Szekely, M L Barbaccia, H Alho and E Costa
      Molecular Pharmacology April 1989, 35 (4) 401-408;

T

  1. Thurman, R G

    1. Interactions between glycolysis and mixed function oxidation: studies with 7-ethoxycoumarin in perfused livers from beta-naphthoflavone-treated rats.
      S A Belinsky, F C Kauffman and R G Thurman
      Molecular Pharmacology April 1989, 35 (4) 512-518;

  2. Triggle, D J

    1. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
      X Y Wei, A Rutledge and D J Triggle
      Molecular Pharmacology April 1989, 35 (4) 541-552;

  3. Tümmler, B

    1. Preparation and utility of a radioiodinated analogue of daunomycin in the study of multidrug resistance.
      R Busche, B Tümmler, J R Riordan and D F Cano-Gauci
      Molecular Pharmacology April 1989, 35 (4) 414-421;

W

  1. Waxman, D J

    1. Hypophysectomy differentially alters P-450 protein levels and enzyme activities in rat liver: pituitary control of hepatic NADPH cytochrome P-450 reductase.
      D J Waxman, J J Morrissey and G A Leblanc
      Molecular Pharmacology April 1989, 35 (4) 519-525;

  2. Wei, X Y

    1. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
      X Y Wei, A Rutledge and D J Triggle
      Molecular Pharmacology April 1989, 35 (4) 541-552;

  3. Wells, P G

    1. In vitro bioactivation of phenytoin to a reactive free radical intermediate by prostaglandin synthetase, horseradish peroxidase, and thyroid peroxidase.
      S Kubow and P G Wells
      Molecular Pharmacology April 1989, 35 (4) 504-511;

  4. Wolfram, C A

    1. Type-A cholecystokinin receptors in CHP212 neuroblastoma cells: evidence for association with G protein and activation of phosphoinositide hydrolysis.
      R W Barrett, M E Steffey and C A Wolfram
      Molecular Pharmacology April 1989, 35 (4) 394-400;

Y

  1. Yamazoe, Y

    1. Expression of a human P-450IIC gene in yeast cells using galactose-inducible expression system.
      T Yasumori, N Murayama, Y Yamazoe, A Abe, Y Nogi, T Fukasawa and R Kato
      Molecular Pharmacology April 1989, 35 (4) 443-449;

  2. Yasumori, T

    1. Expression of a human P-450IIC gene in yeast cells using galactose-inducible expression system.
      T Yasumori, N Murayama, Y Yamazoe, A Abe, Y Nogi, T Fukasawa and R Kato
      Molecular Pharmacology April 1989, 35 (4) 443-449;

Z

  1. Zgombick, J M

    1. Pertussis toxin-sensitive guanine nucleotide-binding protein(S) couple adenosine A1 and 5-hydroxytryptamine1A receptors to the same effector systems in rat hippocampus: biochemical and electrophysiological studies.
      J M Zgombick, S G Beck, C D Mahle, B Craddock-Royal and S Maayani
      Molecular Pharmacology April 1989, 35 (4) 484-494;

  2. Zukin, S R

    1. Biexponential kinetics of [3H]MK-801 binding: evidence for access to closed and open N-methyl-D-aspartate receptor channels.
      D C Javitt and S R Zukin
      Molecular Pharmacology April 1989, 35 (4) 387-393;
Back to top

In this issue

Advertisement